Inactivated measles vaccine and the risk of adverse events

The case history of Mr T.I. Terminal patient or still curable?

Immunology today·2014

WHO and health research--some personal reflections.

World health forum·1999

Awakening the global conscience: who will benefit from new vaccines in the 21st century?

Immunology and cell biology·1998

Host immunobiology and vaccine development.

Lancet (London, England)·1997

The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response.

The EMBO journal·1997

B lymphocyte physiology: the beginning and the end.

Ciba Foundation symposium·1997

Improvements to pharmaceutical manufacturing capacity, Ethiopia.

Bulletin of the World Health Organization·2026

Capacity for national health policy modelling, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates.

Bulletin of the World Health Organization·2026

An oral health module for use in noncommunicable disease risk factor surveys.

Bulletin of the World Health Organization·2026

Seasonal malaria chemoprevention effectiveness and drug resistance in Plasmodium falciparum: a matched parallel cohort study, Kenya.

Bulletin of the World Health Organization·2026

Accountability for large language models in health care.

Bulletin of the World Health Organization·2026

How a 10-minute bout requirement for physical activity affects guideline adherence estimates, Germany.

Bulletin of the World Health Organization·2026

RND efflux pump inhibitor-like natural products as antibiotic adjuvants against multidrug-resistant gram-negative bacteria: a graded-evidence review.

Frontiers in microbiology·2026

Early Severe Moyamoya Disease Due to a Monoallelic RNF213 Variant in Monozygotic Twins.

Neurology. Genetics·2026

Phage therapy for multidrug-resistant pulmonary infections: bridging precision matching, lung delivery, host immunity, and clinical translation.

Frontiers in cellular and infection microbiology·2026

A pharmacist-led framework for antibiotic-associated liver injury: from pharmacovigilance signals to bedside surveillance with the updated RUCAM and susceptibility markers.

Frontiers in pharmacology·2026

Promethazine use and QT prolongation risk during treatment with a shortened all-oral regimen for MDR/RR-TB.

JAC-antimicrobial resistance·2026

Integrative Genomic Analysis Reveals Insulin Resistance as a Key Mediator in the Causal Link between Metabolic Dysfunction-associated Steatohepatitis and Hypertension.

JMA journal·2026

Related Experiment Videos

Inactivated measles vaccine and the risk of adverse events

Related Concept Videos

The case history of Mr T.I. Terminal patient or still curable?

WHO and health research--some personal reflections.

Awakening the global conscience: who will benefit from new vaccines in the 21st century?

Host immunobiology and vaccine development.

The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response.

B lymphocyte physiology: the beginning and the end.

Improvements to pharmaceutical manufacturing capacity, Ethiopia.

Capacity for national health policy modelling, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates.

An oral health module for use in noncommunicable disease risk factor surveys.

Seasonal malaria chemoprevention effectiveness and drug resistance in Plasmodium falciparum: a matched parallel cohort study, Kenya.

Accountability for large language models in health care.

How a 10-minute bout requirement for physical activity affects guideline adherence estimates, Germany.

RND efflux pump inhibitor-like natural products as antibiotic adjuvants against multidrug-resistant gram-negative bacteria: a graded-evidence review.

Early Severe Moyamoya Disease Due to a Monoallelic RNF213 Variant in Monozygotic Twins.

Phage therapy for multidrug-resistant pulmonary infections: bridging precision matching, lung delivery, host immunity, and clinical translation.

A pharmacist-led framework for antibiotic-associated liver injury: from pharmacovigilance signals to bedside surveillance with the updated RUCAM and susceptibility markers.

Promethazine use and QT prolongation risk during treatment with a shortened all-oral regimen for MDR/RR-TB.

Integrative Genomic Analysis Reveals Insulin Resistance as a Key Mediator in the Causal Link between Metabolic Dysfunction-associated Steatohepatitis and Hypertension.

Related Experiment Videos

Inactivated measles vaccine and the risk of adverse events

Related Concept Videos

Related Articles